CHERI TAGGART: Open Payments
NPI 1063583888 · WHEELING, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,134 in 117 payments from 16 companies in 2025. Trend: 2023 $117 · 2024 $1,267 · 2025 $2,134
Food & beverage: $2,134
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 19 | $490 |
| ABBVIE INC. | 28 | $384 |
| Neurocrine BioSciences, Inc. | 21 | $290 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $162 |
| Indivior Inc. | 8 | $152 |
| Teva Pharmaceuticals USA, Inc. | 6 | $141 |
| Alkermes, Inc. | 5 | $114 |
| Janssen Pharmaceuticals, Inc | 5 | $101 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Lundbeck LLC | 4 | $60 |
Products named: VRAYLAR, HETLIOZ, INGREZZA, FANAPT, CAPLYTA, SUBLOCADE, AUSTEDO XR, SPRAVATO.
Industry payments across WV — which companies pay providers there.
